Associate Professor of Radiation Oncology, University Mich Medical School
Radiation Oncology
Dr. James A. Hayman, MD
|
|
Give Review
Dr. James A. Hayman works in the field of Radiation Oncology. He studied medicine at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10 in research and 19 in primary care medicine He received 3 awards: "America's Top Doctors", "America's Top Doctors for Cancer" and "CMS Meaningful Use Stage 1 Certification". James Hayman is a published doctor and has 77 publications published. The lastest was: 'Variation in Definitive Therapy for Localized Non-Small Cell Lung Cancer Among National Comprehensive Cancer Network Institutions.' James Hayman is registered with Medicare and accepts Medicare payments.
Publications
- Variation in Definitive Therapy for Localized Non-Small Cell Lung Cancer Among National Comprehensive Cancer Network Institutions.
- Wide Variation in the Diffusion of a New Technology: Practice-Based Trends in Intensity-Modulated Radiation Therapy (IMRT) Use in the State of Michigan, With Implicati...
- Choosing wisely? Patterns and correlates of the use of hypofractionated whole-breast radiation therapy in the state of michigan.
- Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
- Decline of Cosmetic Outcomes Following Accelerated Partial Breast Irradiation Using Intensity Modulated Radiation Therapy: Results of a Single-Institution Prospective ...
- NCCN Guidelines Implementation in the Multidisciplinary Merkel Cell Carcinoma Program at the University of Michigan.
- Investigation of the diffusion abnormality index as a new imaging biomarker for early assessment of brain tumor response to radiation therapy.
- Summary of oral abstract session B: innovating to improve care quality.
- Gastric Cancer, Version 2.2013.
- Informing Patient Decisions Regarding Management of Ductal Carcinoma In Situ.
- Clinicopathologic Features of Primary Merkel Cell Carcinoma: A Detailed Descriptive Analysis of a Large Contemporary Cohort.
- Physiological imaging-defined, response-driven subvolumes of a tumor.
- Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal Cancer.
- Genetic Variations in TGF?1, tPA, and ACE and Radiation-Induced Thoracic Toxicities in Patients with Non-Small-Cell Lung Cancer.
- Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung Cancer treated with definitive radiation the...
- Effect of radiation therapy on permanent pacemaker and implantable cardioverter-defibrillator function.
- WE-C-BRA-05: Physiological Imaging-Defined Response-Driven Subvolumes of a Tumor.
- SU-E-T-183: Managing and Assessing Patients Receiving Radiotherapy with Implantable Cardiac Devices.
- Radiation therapy at the end of life in patients with incurable nonsmall cell lung Cancer.
- Changes in Global Function and Regional Ventilation and Perfusion on SPECT During the Course of Radiotherapy in Patients with Non-Small-Cell Lung Cancer.
- Modern approaches to localized Cancer of the esophagus.
- Esophageal and esophagogastric junction Cancers.
- Adoption of Intensity-Modulated Radiation Therapy for Breast Cancer in the United States.
- The need for physician leadership in creating a culture of safety.
- Features predicting sentinel lymph node positivity in Merkel cell carcinoma.
- Distribution of proliferating bone marrow in adult Cancer patients determined using FLT-PET imaging.
- Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons.
- Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast Cancer.
- Semiquantification and classification of local pulmonary function by V/Q single photon emission computed tomography in patients with non-small cell lung Cancer: potent...
- Comparative survival in patients with postresection recurrent versus newly diagnosed non-small-cell lung Cancer treated with radiotherapy.
- Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation.
- Accelerated partial breast irradiation: what is dosimetric effect of advanced technology approaches?
- Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung Cancer: a combined analysis from B...
- Treatment recommendations for locally advanced, non-small-cell lung Cancer: the influence of physician and patient factors.
- Time to treatment in patients with stage III non-small cell lung Cancer.
- Treatment summaries in radiation oncology and their role in improving patients' quality of care: past, present, and future.
- The effect of radiation dose and chemotherapy on overall survival in 237 patients with Stage III non-small-cell lung Cancer.
- Designing targets for elective nodal irradiation in lung Cancer radiotherapy: a planning study.
- Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung Cancer and its potential impact on adaptive do...
- Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme.
- Measuring the quality of care in radiation oncology.
- Use of palliative radiotherapy among patients with metastatic non-small-cell lung Cancer.
- A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung Cancer.
- Neoadjuvant docetaxel and capecitabine and the use of thymidine phosphorylase as a predictive biomarker in breast Cancer.
- Long-term results of conservative surgery and radiotherapy for ductal carcinoma in situ using lung density correction: the University of Michigan experience.
- The application of lean thinking to the care of patients with bone and brain metastasis with radiation therapy.
- High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung Cancer.
- Short-term and long-term reproducibility of lung tumor position using active breathing control (ABC).
- Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung Cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.
- Esophageal Cancer Clinical Practice Guidelines.
- Gastric Cancer Clinical Practice Guidelines.
- The role of radiation therapy in thoracic tumors.
- Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung Cancer: is low incidence of regional failure du...
- High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung Cancer: long-term results of a radia...
- The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.
- The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
- CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan.
- Assessing the benefit of radiation therapy after breast-conserving surgery for ductal carcinoma-in-situ.
- A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast Cancer.
- Conservative surgery and radiotherapy for stage I/II breast Cancer using lung density correction: 10-year and 15-year results.
- Cost-effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breast.
- Ophthalmic artery occlusion secondary to radiation-induced vasculopathy.
- Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategy.
- A phase I dose escalation trial of gemcitabine with radiotherapy for breast Cancer in the treatment of unresectable chest wall recurrences.
- Evaluation of the influence of breathing on the movement and modeling of lung tumors.
- Out-of-pocket health-care expenditures among older Americans with Cancer.
- Concurrent cisplatin, paclitaxel, and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma.
- Long-term results of three-dimensional conformal adjuvant and salvage radiotherapy after radical prostatectomy.
- Preliminary visual outcomes after three-dimensional conformal radiation therapy for optic nerve sheath meningioma.
- Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability.
- The use of preferences to measure the benefit of adjuvant radiation therapy for stage I seminoma.
- Comparing the costs of radiation therapy and radical prostatectomy for the initial treatment of early-stage prostate Cancer.
- Decision-analytic model and cost-effectiveness evaluation of postmastectomy radiation therapy in high-risk premenopausal breast Cancer patients.
- Regression rate of posterior uveal melanomas following iodine-125 plaque radiotherapy.
- Dosimetric review of cardiac implantable electronic device patients receiving radiotherapy.
- Diffusion abnormality index: a new imaging biomarker for early assessment of tumor response to therapy.
Schools
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Evanston Hospital
Joint Center For Rad Therapy
Conditions Treated
- Pituitary Gland Cancer
- Vulvar Cancer
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Chicago Pritzker School of Medicine
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1245322643 | |
| NPPES Provider LastName | HAYMAN | |
| NPPES Provider FirstName | JAMES | |
| NPPES Provider ZIPCode | 481095010 | |
| NPPES Provider State | MI | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 28.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1245322643 |
| Last Name Of The Provider | HAYMAN |
| First Name Of The Provider | JAMES |
| View All |
Similar Doctors
|
|
Dr. Eyad Abu-Isa, MD |
|
|
Dr. Daniel A. Hamstra, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Annette E. Kretzler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Reshma Jagsi, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Christina I. Tsien, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary U. Feng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jae Y. Lee, MD |
|
|
Dr. Matthew H. Stenmark, MD
This Doctor is OpenDoctor Recommended.
|